Source: ERJ Open Res, 6 (1) 00221-2019; 10.1183/23120541.00221-2019
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Sharina Kort, Marjolein Brusse-Keizer, Jan Willem Gerritsen, Hugo Schouwink, Emanuel Citgez, Frans de Jongh, Jan van der Maten, Suzy Samii, Marco van den Bogart, Job van der Palen. Improving lung cancer diagnosis by combining exhaled-breath data and clinical parameters. ERJ Open Res, 6 (1) 00221-2019; 10.1183/23120541.00221-2019

Member's Comments

No comment yet.

Related content which might interest you: Combining exhaled-breath analysis data with clinical parameters to improve the diagnosis of lung cancer Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019 Improving lung cancer diagnosis from exhaled-breath analysis by adding clinical parameters to the artificial neural network Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019 A practical measurement of thoracic sarcopenia: correlation with clinical parameters and outcomes in advanced lung cancer Source: ERJ Open Res 2016: 00085-2015 Year: 2016 A basic prediction model with clinical parameters to diagnose lung cancer. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021 Non-invasive biomarkers for the evaluation of a patient at risk for lung cancer Source: Annual Congress 2013 –Early detection of lung cancer Year: 2013 Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Scintigraphic parameters in differential diagnostics of community acquired pneumonia and lung cancer Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009 Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Source: Eur Respir J, 51 (6) 1800602; 10.1183/13993003.00602-2018 Year: 2018 Cost-effectiveness of biomarker testing for treatment choices in advanced non-small cell lung carcinoma: impact of diagnostic strategies and their turnaround times Source: Eur Respir J, 51 (6) 1800844; 10.1183/13993003.00844-2018 Year: 2018 Feasibility study of cryobiopsy for practical pathological diagnosis including immunohistochemical assessment of primary lung cancer Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 Comparision of two preoperative risk assessment algorithms in lung cancer surgery. Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Evaluation of breath sampling procedures in lung cancer patients Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008 Defining a standard set of patient-centred outcomes for lung cancer Source: Eur Respir J 2016; 48: 852-860 Year: 2016 Lung function testing for the preoperative evaluation of patients with lung cancer Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003 Interpreting lung function in clinical practice Source: Annual Congress 2006 - PG5 - Respiratory physiology: interpreting lung function in health and disease Year: 2006 Possibility of noninvasive differential diagnostics of lung tuberculosis and lung cancer in oncologic hospital Source: Eur Respir J 2003; 22: Suppl. 45, 160s Year: 2003 Comparison of different staging methods for COPD in predicting outcomes Source: Eur Respir J, 51 (3) 1700577; 10.1183/13993003.00577-2017 Year: 2018 Interstitial lung disease associated by gemcitabine chemotherapy in non-small lung cancer patients: Analysis based on the data in practical use with confirmed denominator Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases Year: 2011 Clinical management implications of histologic information provided by lung biopsy in the multidisciplinary evaluation of interstitial lung diseases. Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020